Clinical Trials

Showing trials with last updates posted in 2024.

NCT03918460 | RECRUITING | NA
40 participants

ANEUFIX for Endoleak Type II Repair

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-10
Start Date:
2020-05-13
Completion:
2025-08-31
Conditions
  • Abdominal Aortic Aneurysm
  • Endoleak
Interventions
  • DEVICE
No Results Yet
NCT03744351 | COMPLETED | NA
136 participants

B Cell Differentiation in MS

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-10
Start Date:
2019-02-25
Completion:
2023-05-30
Conditions
  • Multiple Sclerosis
Interventions
  • OTHER
No Results Yet
NCT03664791 | ACTIVE_NOT_RECRUITING
450 participants

Vanguard Rocc Post Market Surveillance

Study Type:
OBSERVATIONAL
Last Updated:
2024-04-10
Start Date:
2009-10-23
Completion:
2024-12-31
Conditions
  • Osteoarthritis, Knee
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Posttraumatic Deformity
  • Varus Deformity
  • Valgus Deformity
  • Osteotomy
  • Arthrodesis
Interventions
  • PROCEDURE
No Results Yet
NCT03410810 | RECRUITING
80 participants

Childhood Outcomes of Preterm Brain Abnormalities

Study Type:
OBSERVATIONAL
Last Updated:
2024-04-10
Start Date:
2018-03-01
Completion:
2025-08-01
Conditions
  • Premature Birth
  • Neurodevelopmental Disorders
  • Brain Development Abnormality
  • Brain Lesion
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT03395717 | COMPLETED | NA
162 participants

Stroke Rehabilitation With Exoskeleton-assisted Gait.

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-10
Start Date:
2016-03-16
Completion:
2018-11-01
Conditions
  • Severe Stroke
  • Acute Stroke
  • Chronic Stroke
  • Cerebrovascular Disorders
  • Brain Diseases
  • Central Nervous System Diseases
  • Vascular Diseases
  • Cardiovascular Diseases
  • Mild Stroke
Interventions
  • DEVICE
No Results Yet
NCT03103971 | TERMINATED | PHASE1
55 participants

huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-10
Start Date:
2017-11-03
Completion:
2023-03-23
Conditions
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Refractory Adult Acute Lymphoblastic Leukemia
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Recurrent Transformed Non-Hodgkin Lymphoma
  • Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page